Hanall Biopharma Analysis
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
74.00
|
115.00
|
41.00
|
55.41%
|
|
2022-06-30
|
74.00
|
115.00
|
41.00
|
55.41%
|
|
2022-03-31
|
74.00
|
115.00
|
41.00
|
55.41%
|
|
2021-12-31
|
74.00
|
115.00
|
41.00
|
55.41%
|
|
2021-09-30
|
0.00
|
40.22
|
0.00
|
0.00%
|
|
2021-06-30
|
0.00
|
63.69
|
0.00
|
0.00%
|
|
2021-03-31
|
0.00
|
88.40
|
0.00
|
0.00%
|
|
2020-12-31
|
0.00
|
122.65
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
345.00
|
|
2021-12-31
|
307.31
|
|
2020-12-31
|
386.44
|
|
2019-12-31
|
374.67
|
|
2018-12-31
|
64.65
|
|
2017-12-31
|
113.61
|
|
2016-12-31
|
39.85
|
|
2015-12-31
|
-143.68
|
|
2014-12-31
|
-314.85
|
|
2013-12-31
|
-529.28
|
|
2012-12-31
|
-81.23
|
|
2011-12-31
|
-413.74
|
|
2010-12-31
|
6.40
|
|
2009-12-31
|
17.75
|